… with Covid-19, we randomly assigned patients to receive oral or intravenous dexamethasone
(… show that among hospitalized patients with Covid-19, the use of dexamethasone for up to …

… of patients hospitalized for COVID-19, we found that dexamethasone use administered …
150 mg was associated with reduced mortality only in patients requiring respiratory support. …

… patients who were hospitalized with Covid-19, we randomly assigned patients to receive oral
or intravenous dexamethasone (… of 2104 patients were assigned to receive dexamethasone …

… -19) has recently suggested to use dexamethasone in hospitalized patients who require …
trial that assigned 6 mg dexamethasone to patients hospitalized with COVID-19, taken once …

… ’ 19 although in China, corticosteroids are recommended for severe … corticosteroids. Here
we report the results of a randomized controlled trial of dexamethasone in patients hospitalized …

… use of dexamethasone in hospitalized patients with COVID-19 respiratory illness and to
explore the propensity-adjusted association with in-hospital … across different patient subgroups, …

… properties, role in COVID-19 patients suffering from pneumonia, the proposed mode of …
the usage of corticosteroids in COVID-19 patients. The corticosteroids such as dexamethasone …

… might increase mortality in hospitalised patients who were not receiving … dexamethasone
use in patients with severe COVID-19 have changed clinical practice for hospitalised patients …

… Meaning The findings of this study suggest that prescribing dexamethasone at discharge
for patients hospitalized with COVID-19 who received less than 10 days of dexamethasone is …

… We hypothesized that early corticosteroids would combat the inflammatory cascade …
Patients with confirmed influenza infection were not recommended to receive early corticosteroids…